Novo Nordisk is slashing the cost of Ozempic for cash-paying patients after the diabetes shot became the poster child for high US drug prices.
Business / Companies
Brisbane Times – Business
Business
More in:Business
Business
Strickland shifts focus after $45M equity sale of WA gold project
Strickland Metals will shift its focus to Serbia after the $45M equity sale of its ...
Business
Infini lines up shallow uranium targets in Canada’s land of the giants
Infini Resources has identified 14 new high-priority uranium targets from a desktop study at its ...
Business
Lindian locks in $91.5M to greenlight Malawi rare earths mine
Lindian locks in $91.5M to greenlight Malawi rare earths mine Business / Companies Brisbane Times ...